Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$11K Sell
116
-756
-87% -$84.9K ﹤0.01% 8706
2014
Q2
$112K Buy
872
+581
+200% +$72.6K ﹤0.01% 5801
2014
Q1
$36K Buy
+291
New +$33.4K ﹤0.01% 7277
2013
Q4
Sell
-58
Closed -$6K 10484
2013
Q3
$6K Sell
58
-3,777
-98% -$348K ﹤0.01% 9247
2013
Q2
$344K Buy
+3,835
New +$316K ﹤0.01% 4498

Other funds holding ENOV

UBS's ENOV Position: Q3 2014 in Review

UBS reduced its Enovis (ENOV) stake by 37% in Q3 2014, selling an estimated $9.46M and leaving 144,076 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #1182.

UBS first reported a position in ENOV in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.2M in Q1 2014. 211 funds tracked by Wall St. Rank hold ENOV as of Q3 2014.

  • UBS held 144,076 shares of Enovis worth $14.1M as of Q3 2014.
  • UBS sold 84,256 Enovis shares in Q3 2014, an estimated $9.46M.
  • Enovis made up 0.01% of UBS's portfolio in Q3 2014, its #1182 holding.
  • UBS first reported a position in Enovis in Q2 2013 and has held it in 6 quarters since.
  • UBS's Enovis position peaked at $31.2M in Q1 2014.
  • 211 funds tracked by Wall St. Rank held Enovis as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.